Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-133320
Filing Date
2024-12-04
Accepted
2024-12-04 16:47:07
Documents
1
Period of Report
2024-12-02

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 11358
  Complete submission text file 0000950170-24-133320.txt   12848
Mailing Address 201 MAIN STREET SUITE 1900 FORT WORTH TX 76102
Business Address
BRATTON DOUGLAS K (Reporting) CIK: 0001281933 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38599 | Film No.: 241526773

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)